ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Human Tissue Available Through NCI Network

July 10, 1987